8-K
Current Report
ARS Pharmaceuticals, Inc. Filed Acc 0001193125-23-044823
Material agreement · Agreement ended
- Item 1.01 Entry into a material definitive agreement
- Item 1.02 Termination of a material definitive agreement
From the SEC's structured data for this filing
Loading d469633d8k.htm…